CONTEXT: This retrospective analysis of an at-home monitoring system gives hope for suffers of age-related macular degeneration (AMD) | The large sale analysis of US patients showed the system could detect wet AMD significantly earlier than standard of care, enabling patient to get treatment and help prevent progression of the disease and the ensuing sight loss | RWD showing how patient engagement really helps make a difference to a very debilitating disease.
IMPACT: Medium
READ TIME: 2 mins
Quality Level Mean [1 – 10]: 8
1. “Manassas, VA, April 06, 2021 (GLOBE NEWSWIRE) — Real-world data on the performance of the ForeseeHome® AMD Monitoring Program, a home-based diagnostic that helps detect the conversion from intermediate dry to wet age-related macular degeneration (AMD), was recently published in the Journal of Clinical Medicine as part of the “Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration” special issue1.”
2. “The retrospective analysis of medical records from the Notal Vision Diagnostic Clinic in Manassas, VA, medical provider of the ForeseeHome remote monitoring program, identified 306 eyes that converted to wet AMD between October 2009 and September 2018.”
3. ““This real-world data analysis confirms that the use of ForeseeHome provides a significant benefit to patients as a means of increasing the early detection of wet AMD when vision is good,” said Allen C. Ho, MD, the study’s principal author and Director of Retina Research of Wills Eye Hospital and Professor of Ophthalmology at the Kimmel School of Medicine at Thomas Jefferson University.”
4. “www.notalvision.com. The ForeseeHome® AMD Monitoring Program is a comprehensive program, which includes an FDA-cleared device that monitors visual changes in intermediate dry AMD patients at risk of vision loss from undiagnosed wet AMD.”
5. “The clinical utility for ForeseeHome was established in the Home Monitoring of The Eye (HOME) Study, part of the National Eye Institute-sponsored AREDS2 study, in which 94% of patients using ForeseeHome twice weekly who progressed to wet AMD, maintained 20/40 or better vision compared to only 62% of patients whose diagnosis was at a routine eye exam or a visit triggered by symptoms.”